Kwality Pharmaceuticals Q3 FY24 Results Live: Profit Rise by 7% YoY
Kwality Pharmaceuticals Q3 FY24 Results Live: Revenue increased by 38.95% YoY & profit increased by 7% YoY
Kwality Pharmaceuticals declared their Q3 FY24 results on 06 Feb, 2024. The topline increased by 38.95% & the profit increased by 7% YoY. As compared to the previous quarter, the revenue grew by 12.13% and the profit increased by 23.32%.
The Selling, general & administrative expenses rose by 1.06% q-o-q & decreased by 0.49% Y-o-Y.
The operating income was up by 14.69% q-o-q & increased by 2.78% Y-o-Y.
The EPS is ₹7.39 for Q3 FY24 which increased by 8.36% Y-o-Y.
Kwality Pharmaceuticals has delivered 7.2% return in the last 1 week, 24.14% return in the last 6 months and 19.05% YTD return.
Currently, Kwality Pharmaceuticals has a market cap of ₹493.86 Cr and 52wk high/low of ₹525 & ₹248 respectively.
Kwality Pharmaceuticals Financials
| Period | Q3 FY24 | Q2 FY24 | Q-o-Q Growth | Q3 FY23 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 78.09 | 69.65 | +12.13% | 56.2 | +38.95% |
| Selling/ General/ Admin Expenses Total | 8.01 | 7.92 | +1.06% | 8.05 | -0.49% |
| Depreciation/ Amortization | 4.82 | 4.88 | -1.34% | 3.55 | +35.6% |
| Total Operating Expense | 66.23 | 59.3 | +11.68% | 44.66 | +48.3% |
| Operating Income | 11.87 | 10.35 | +14.69% | 11.54 | +2.78% |
| Net Income Before Taxes | 9.75 | 8.17 | +19.36% | 9.95 | -1.98% |
| Net Income | 7.69 | 6.24 | +23.32% | 7.19 | +7% |
| Diluted Normalized EPS | 7.39 | 5.99 | +23.37% | 6.82 | +8.36% |
Catch all the Business News , Corporate news , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.